Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial towards patient enrolment, with key…
In 2023, cancer is responsible for about three in 10 deaths across Australia. And among women, breast cancer remains the…
Biotech company Imagion Biosystems (ASX: IBX) has secured a major boost in resources having secured Siemens Healthineers (FWB: SHL) as…